TCC Signs Another Life Sciences Tenant at Fulton Labs in Chicago

Trammell Crow Company (TCC), a global commercial real estate developer, signed a lease with Charles River Laboratories’ (CRL), at its Fulton Labs campus in Chicago. The company will occupy 8,776 square feet of space on the seventh floor of 1375 West Fulton, which together with nearby 400 North Aberdeen, makes up TCC’s 725,000-square-foot Fulton Labs life sciences campus.

“Watching Fulton Labs come to life over the last few years has been an incredible journey for TCC and our project partners. The state-of-the-art campus is attracting users in the life sciences space that are seeking high-quality lab and office space that affords them an opportunity to grow in Chicago. We are energized to see the continued interest in the Fulton Labs properties, as well as the heighted interest in Chicago as a top-tier life sciences market,” said Morgan Baer-Blaska, Vice President with TCC. “We look forward to welcoming CRL into their new space at Fulton Labs later this year.”

CRL’s CRADL business already occupies 10,000 square feet on the ground floor at 1375 West Fulton. The campus was designed to meet the needs of the growing companies like CRL, which will use their expansion space to accelerate and augment their own clients’ discovery efforts.

TCC was represented in the transaction by Dan Lyne and Kelsey Scheive of CBRE. The tenant was represented by Paul Giannopulos, Matt Schiffler, Brendan Callahan, and Peter Skerrett of JLL.

Other tenants at Fulton Labs include Chan Zuckerberg Biohub Chicago, Dimension Inx, Celadyne Technologies, Portal Innovations, Xeris Pharmaceuticals, Vanqua Bio and Talis Biomedical.